Physician-scientists urge FDA to approve Capricor's deramiocel

A letter dated October 25, 2026, written by 28 physician-scientists and researchers involved in the HOPE-3 trial, was submitted to senior FDA leadership advocating for approval of Capricor's deramiocel.

Detected & updated continuously · Source: Nebula